Erratum: Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With BRAFV600-Mutant Metastatic Non–Small-Cell Lung Cancer Risk Factors for Primary Bone Cancer After Childhood Cancer: ...
Biomarker changes that occur in the period between normal cognition and the diagnosis of sporadic Alzheimer’s disease have not been extensively investigated in longitudinal studies. We conducted a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results